Breaking News Headlines Today

News about Gene Editing

Stay current with all the latest and breaking news about Gene Editing, compare headlines and perspectives between news sources on stories happening today. In total, 60stories have been published about Gene Editing which Ground News has aggregated in the past 3 months.

Covered Most By

Nature

Center

GEN - Genetic Engineering and Biotechnology News…

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Gene Editing News

Gene Editing

Prime Editing Repairs Five Genetic Mutations to Treat Rare Brain Disorder in Mice

100% Center coverage: 4 sources

By the time they are a few months old, infants born with alternating hemiplegia of childhood (AHC) begin experiencing terrifying episodes of paralysis and seizures, and will soon show developmental delays and intellectual disability. There is no cure or effective treatment for this rare genetic disease, but new research suggests a potential path to one.See the Story

Gene Editing

Gene Editing Offers Transformative Solution to Saving Endangered Species

100% Center coverage: 3 sources

Gene editing technologies—such as those used in agriculture and de-extinction projects—can be repurposed to offer what an international team of scientists is calling a transformative solution for restoring genetic diversity and saving endangered species.See the Story

Gene Editing

Vertex, CRISPR Therapeutics Land On TIME's Most Influential Companies List - IndiaWest Journal News

100% Center coverage: 1 sources

Time India-West News Desk NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential Companies. The recognition highlights their significant contributions to gene therapy and drug development. Vertex Pharmaceuticals, under the leadership of CEO Reshma Kewalramani, was named in the “Impact Awards” category, …See the Story

Eli Lilly acquires Verve Therapeutics in $1.3 billion deal, validating gene editing for heart disease

Eli Lilly and Co. has agreed to buy Verve Therapeutics Inc. for up to $1.3 billion, in a move that bolsters Lilly’s push into gene editing for cardiovascular conditions and signals renewed confidence in the sector. The all-cash tender offer values Verve at $10.50 per share upfront. That’s a 113% premium over the company’s 30-day… The post Eli Lilly acquires Verve Therapeutics in $1.3 billion deal, validating gene editing for heart disease appear…Gene Editing · Indianapolis Read Article

Scientists Launch Controversial Push To Synthesize Human DNA

100% Center coverage: 1 sources

What if we could write human DNA the same way we write code? That future may be closer than you think.British scientists have just launched a bold new project aiming to build artificial human DNA from the ground up. A move that could revolutionize medicine and tech.According to The i Paper, the UK has poured £10 million into the Synthetic Human Genome (SynHG) project. The project is backed by the Wellcome Trust, the world’s largest medical char…Gene Editing · United Kingdom Read Article

Dynamically Covalent Lipid Nanoparticles Mediate CRISPR-Cas9 Genome Editing against Choroidal Neovascularization in Mice

Dynamically covalent lipid nanoparticles were engineered to mediate vascular endothelial growth factor A (VEGFA) gene editing and choroidal neovascularization treatment by codelivering Cas9 mRNA and single guide RNA targeting VEGFA. [Science Advances] Full ArticleGene Editing Read Article

GalNAc-Lipid Nanoparticles Enable Non-LDLR Dependent Hepatic Delivery of a CRISPR Base Editing Therapy

100% Center coverage: 1 sources

Lipid nanoparticles have demonstrated utility in hepatic delivery of a range of therapeutic modalities and typically deliver their cargo via low-density lipoprotein receptor-mediated endocytosis. For patients lacking sufficient low-density lipoprotein receptor activity, such as those with homozygous familial hypercholesterolemia, an alternate strategy is needed. Here we show the use of structure-guided rational design in a series of mouse and no…Software See the Story

Indian scientists are arming plants through gene editing. And climate-proofing them

100% Right coverage: 1 sources

‘We have pampered our plants so much that they have lost their ability to fight against what’s trying to kill them,' said Shivaprasad, associate dean of research, NCBS, Bengaluru.Gene Editing · Bengaluru Read Article

News about Gene Editing

News about Gene Editing

Covered Most By

Local News Publishers

Top Gene Editing News

Prime Editing Repairs Five Genetic Mutations to Treat Rare Brain Disorder in Mice

Gene Editing Offers Transformative Solution to Saving Endangered Species

Vertex, CRISPR Therapeutics Land On TIME's Most Influential Companies List - IndiaWest Journal News

Healing from Within: The Science (and Surprising Simplicity) of PRP

Peru considers gene editing to protect potatoes

METiS Debuts AI Nanodelivery Tech at 2025 CRS Annual Meeting - AI-Tech Park

Eli Lilly acquires Verve Therapeutics in $1.3 billion deal, validating gene editing for heart disease

Scientists Launch Controversial Push To Synthesize Human DNA

Dynamically Covalent Lipid Nanoparticles Mediate CRISPR-Cas9 Genome Editing against Choroidal Neovascularization in Mice

GalNAc-Lipid Nanoparticles Enable Non-LDLR Dependent Hepatic Delivery of a CRISPR Base Editing Therapy

Indian scientists are arming plants through gene editing. And climate-proofing them

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Gene Editing

Healing from Within: The Science (and Surprising Simplicity) of PRP

Peru considers gene editing to protect potatoes

METiS Debuts AI Nanodelivery Tech at 2025 CRS Annual Meeting - AI-Tech Park

Eli Lilly acquires Verve Therapeutics in $1.3 billion deal, validating gene editing for heart disease

Scientists Launch Controversial Push To Synthesize Human DNA

Dynamically Covalent Lipid Nanoparticles Mediate CRISPR-Cas9 Genome Editing against Choroidal Neovascularization in Mice

GalNAc-Lipid Nanoparticles Enable Non-LDLR Dependent Hepatic Delivery of a CRISPR Base Editing Therapy

Indian scientists are arming plants through gene editing. And climate-proofing them